Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 92, Issue 4, Pages 883-893Publisher
FEDERATION AMER SOC EXP BIOL
DOI: 10.1189/jlb.0412177
Keywords
adjuvant; B cell; T cell; cytokine plasma cell
Categories
Funding
- U.S. National Institutes of Health [RO1 AI078993, U19 AI062629]
Ask authors/readers for more resources
Alum-based adjuvants facilitate vaccine-driven humoral immunity, but their mechanism of action remains poorly understood. Herein, we report that lack of type II NKT cells is associated with intact, mature B cells but dampened humoral immunity following immunization with Alum-adsorbed T-dependent antigen. Type II NKT cells facilitated production of IL-4, IL-5, IL-10, IL-13, and antibody by LN and splenocyte cultures following Alum/antigen administration in vivo and antigen restimulation in vitro. Addition of IL-4 and IL-5 to type II NKT-deficient cultures restored in vitro antibody production. Intracellular staining revealed that Alum-primed type II NKT cells coordinated IL-4 secretion by T cells. Alum did not significantly affect CD1d expression in vivo, but addition of CD1d-blocking mAb diminished cytokine production and in vitro antibody production. Type II NKT cells therefore function as part of the Alum-sensing apparatus and in a CD1d-dependent manner, facilitate TH2-driven humoral immunity. This may have important consequences for understanding the mechanism of action of Alum-containing vaccines. J. Leukoc. Biol. 92: 883-893; 2012.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available